rs1555850151
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_172107.4(KCNQ2):c.2599_2603dupTGGGC(p.Arg871GlyfsTer61) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_172107.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.2599_2603dupTGGGC variant, located in coding exon 17 of the KCNQ2 gene, results from a duplication of TGGGC at nucleotide positions 2599 to 2603. This duplication and subsequent frameshift occur near the 3' terminus of KCNQ2, is not expected to trigger nonsense mediated decay (NMD), and predicted to result in the elongation of the protein (p.R871Gfs*61). This alteration was first reported in a mother and daughter who had a diagnosis of benign familial neonatal epilepsy; while both had neonatal seizures, the daughter continued to have seizures outside of the neonatal period (Soldovieri MV et al. Hum Mutat. 2014; 35(3):356-67). Another study identified a different nucleotide change that results in the same protein change (referred to as 867ins) in a family with neonatal seizures; in vitro functional analysis indicated this alteration results in a dominant-negative affect and a >50% reduction in current magnitude (Singh NA et al. Brain. 2003; 126(Pt 12):2726-37). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), 1000 Genomes Project, and ExAC. In the ESP, this variant was not observed in 6196 samples (12392 alleles) with coverage at this position. In addition to the clinical and functional data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a variant is likely to be pathogenic (ACMG Standards and guidelines for the interpretation of sequence variants. Genet Med. 2015;17(5):405-24). -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change results in a frameshift in the KCNQ2 gene (p.Arg871Glyfs*61). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2 amino acid(s) of the KCNQ2 protein and extend the protein by 58 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individuals with benign familial neonatal seizures (PMID: 14534157, 24375629). It has also been observed to segregate with disease in related individuals. Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this frameshift affects KCNQ2 function (PMID: 14534157). For these reasons, this variant has been classified as Pathogenic. -
Seizures, benign familial neonatal, 1 Other:1
BFNE (benign familial neonatal epilepsy) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at